Aigen Investment Management, LP Bio N Tech Se Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $443,640 - $550,220	4,880 New	4,880 $515,000
Q1 2022 May 05, 2022	SELL	$126.25 - $231.85 $2.38 Million - $4.37 Million	-18,839 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $4.08 Million - $6.83 Million	18,839 New	18,839 $5.09 Million
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $1.63 Million - $3.54 Million	-7,913 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$113.32 - $241.49 $896,701 - $1.91 Million	7,913 New	7,913 $1.77 Million

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.